Last Posted: Apr 12, 2018
- Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
Minig L, et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2018 4 - NIH study revises molecular classification for most common type of lymphoma
NIH News, Apr 11, 2018 - Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi.
Zaja Francesco et al. Leukemia & lymphoma 2018 Apr 1-7 - The Impact of Drug Metabolism Gene Polymorphisms on Therapeutic Response and Survival in Diffuse Large B-Cell Lymphoma Patients.
Pál Ildikó et al. The Israel Medical Association journal : IMAJ 2018 Apr 20(4) 217-221 - Clinical utility of cell-free DNA for the detection of ALK fusions and genomic mechanisms of ALK inhibitor resistance in non-small cell lung cancer.
McCoach Caroline E et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Mar - Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario.
Addeo Alfredo et al. Critical reviews in oncology/hematology 2018 Feb 122150-156
No hay comentarios:
Publicar un comentario